How much funding has Abdera Therapeutics raised?

Abdera Therapeutics has raised $142.0M in total funding, most recently a Series A round.

Who are Abdera Therapeutics's investors?

Abdera Therapeutics's investors include Jerel Davis, Amplitude Ventures, venBIO Partners, Northview, adMare Bio Innovations, Viking Global.

When was Abdera Therapeutics founded?

Abdera Therapeutics was founded in 2020.

Where is Abdera Therapeutics headquartered?

Abdera Therapeutics is headquartered in San Diego, California, United States.

What industry is Abdera Therapeutics in?

Abdera Therapeutics operates in Biotech, Healthcare.

How many employees does Abdera Therapeutics have?

Abdera Therapeutics has 11-50 employees.

Abdera Therapeutics

San Diego, United States · Founded 2020 · $142.0M raised

Biotech

Healthcare

Headquarters: San Diego, California
Employees: 11–50
Founded: 2020
Business Model: B2B

Website: abderatx.com
Total Funding: $142.0M
Last Round: $32.0M Series AJan 2021
Rounds: 2

About

Abdera Therapeutics is a precision oncology biopharmaceutical company leveraging antibody engineering to design and develop next-generation targeted radiopharmaceuticals for patients with relapsed, refractory, and advanced cancers. The company's platform uses tunable, antibody-based constructs to deliver targeted radiation directly to tumor cells, enabling highly specific cancer cell killing while minimizing damage to surrounding healthy tissue. Founded in 2020 and headquartered in San Diego, California, Abdera debuted with $142 million in financing to advance its pipeline of precision radiopharmaceutical therapies.

Summary

Abdera Therapeutics is a Biotech company based in San Diego, United States, founded in 2020. It has raised $142.0M in total across 2 rounds, most recently a $32.0M Series A round in Jan 2021. Investors include Jerel Davis, Amplitude Ventures and venBIO Partners.